Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

BACKGROUND: Historically, warfarin or aspirin have been the recommended therapeutic options for the extended treatment (>3 months) of VTE. Data from Phase III randomised controlled trials (RCTs) are now available for non-VKA oral anticoagulants (NOACs) in this indication. The current systematic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, A. T., Hamilton, M., Bird, A., Mitchell, S. A., Li, S., Horblyuk, R., Batson, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972314/
https://www.ncbi.nlm.nih.gov/pubmed/27487187
http://dx.doi.org/10.1371/journal.pone.0160064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972314/
https://www.ncbi.nlm.nih.gov/pubmed/27487187
http://dx.doi.org/10.1371/journal.pone.0160064

Ejemplares similares